Antifungals and Drug Resistance

Antifungals and Drug Resistance

Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth of fungi (termed fungistatic) or by killing the fungal cells (termed fungicidal). Antibiotics also prevent bacterial infections through either bacteriostatic or bactericidal mechanisms. These microorga...

Full description

Bibliographic Details
Main Authors:	Chowdhury Mobaswar Hossain, Lisa Kathleen Ryan, Meeta Gera, Sabyasachi Choudhuri, Nazmun Lyle, Kazi Asraf Ali, Gill Diamond
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Encyclopedia
Subjects:	antifungal drugs drug resistance fungal infections regulation mycoses
Online Access:	https://www.mdpi.com/2673-8392/2/4/118

Similar Items

Topical antifungals in treatment of superficial cutaneous mycoses
by: Olga B. Tamrazova
Published: (2024-06-01)

Interactions of yeasts, moulds, and antifungal agents : how to detect resistance /
by: Hall, Gerri S.
Published: (c201)

Groups of antifungal drugs with role in animal health - Synthesis
by: Răzvan F. Moruzi, et al.
Published: (2021-06-01)

Amphotericin B in the Era of New Antifungals: Where Will It Stand?
by: Karolina Akinosoglou, et al.
Published: (2024-04-01)

Immunotherapy and Antifungal Drugs of Candidiasis: Achievements and Challenges
by: leili Aghebati-Maleki, et al.
Published: (2021-10-01)

Special Issue: Novel Antifungal Drug Discovery
by: Maurizio Del Poeta
Published: (2016-12-01)

Antifungal chemotherapy: advances and perspectives
by: AH Groll, et al.
Published: (2002-06-01)

Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in <i>Candida</i> Pathogens
by: Jehoshua Sharma, et al.
Published: (2019-02-01)

Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy
by: Gina Wall, et al.
Published: (2020-07-01)

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
by: Kyle McEvoy, et al.
Published: (2020-08-01)

Antifungal Drug Resistance: An Emergent Health Threat
by: Antonio Vitiello, et al.
Published: (2023-03-01)

Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
by: Hua Zhong, et al.
Published: (2022-12-01)

Antifungal Drugs
by: Jiří Houšť, et al.
Published: (2020-03-01)

In vitro Antifungal Susceptibility of Agents for Superficial Phaeohyphomycosis
by: Viviane Pagnussat, et al.
Published: (2020-07-01)

Development and research progress of anti-drug resistant fungal drugs
by: Xiangyi Cui, et al.
Published: (2022-09-01)

Fungal Spectrum and Susceptibility Against Nine Antifungal Agents in 525 Deep Fungal Infected Cases
by: Cai W, et al.
Published: (2023-07-01)

Antifungal Activities of Natural Products and Their Hybrid Molecules
by: Vuyolwethu Khwaza, et al.
Published: (2023-11-01)

Vitamin Biosynthesis as an Antifungal Target
by: Zohar Meir, et al.
Published: (2018-06-01)

Editorial: Antifungal Pipeline: Build It Strong; Build It Better!
by: John R. Perfect, et al.
Published: (2022-03-01)

Bioadhesive polymer in antifungal drug delivery for therapeutic treatment of candidiasis
by: Muhamad Naquib Faisal Roslan, et al.
Published: (2024-07-01)

Rotenone enhances antifungal activity of novel pyrazoles against Candida spp.
by: Luis Fernando Quejada, et al.
Published: (2022-08-01)

Candida Antifungal Resistance and Therapeutic Approach
by: Francisca Vieira, et al.
Published: (2017-08-01)

Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections
by: Kévin Brunet, et al.
Published: (2022-03-01)

Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections
by: Cheng Zhen, et al.
Published: (2022-06-01)

Skin Immunity to Dermatophytes: From Experimental Infection Models to Human Disease
by: Verónica L. Burstein, et al.
Published: (2020-12-01)

Progress of polymer-based strategies in fungal disease management: Designed for different roles
by: Siyu Wu, et al.
Published: (2023-03-01)

Unraveling the importance of molecules of natural origin in antifungal drug development through targeting ergosterol biosynthesis pathway
by: Fatemehsadat Jamzivar, et al.
Published: (2020-01-01)

Novel 2-Thiazolylhydrazone with Druggable Properties for Antifungal Application
by: Wallace Cordeiro de Morais, et al.
Published: (2025-01-01)

In vitro activities of antifungal agents alone and in combination against fluconazole-susceptible and -resistant strains of Candida dubliniensis
by: Liliane Alves Scheid, et al.

Repurposing antifungal drugs for cancer therapy
by: Ningna Weng, et al.
Published: (2023-06-01)

The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives
by: Cássia Milena de Souza, et al.
Published: (2025-01-01)

Pre-Existing Liver Disease and Toxicity of Antifungals
by: Nikolaos Spernovasilis, et al.
Published: (2018-12-01)

Biogenic silver nanoparticles as antifungal agents
by: Javier Mussin, et al.
Published: (2022-10-01)

Identification of Promising Antifungal Drugs against <i>Scedosporium</i> and <i>Lomentospora</i> Species after Screening of Pathogen Box Library
by: Rodrigo Rollin-Pinheiro, et al.
Published: (2021-09-01)

Updating information of mycoses and antifungal medicines to find effective platforms for the production of new thiazole compounds
by: T. F. Chernykh, et al.
Published: (2024-11-01)

New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions
by: Gustavo A. Niño-Vega, et al.
Published: (2024-12-01)

Novel Antifungal Agents and Their Activity against <i>Aspergillus</i> Species
by: Roya Vahedi-Shahandashti, et al.
Published: (2020-10-01)

Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
by: Daniela Baracaldo-Santamaría, et al.
Published: (2022-05-01)

Another point of view on side effects of antifungal compounds used in veterinary medicine
by: Carmen Lidia Chitescu,, et al.
Published: (2011-06-01)

Burden of Fungal Infections in Colombia
by: Carlos Arturo Alvarez-Moreno, et al.
Published: (2018-03-01)